2 papers
stat.ME2025
A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
Moka Komaki, Satoru Shinoda, Haiyan Zheng +1
It is crucial to design Phase II cancer clinical trials that balance the efficiency of treatment selection with clinical practicality. Sargent and Goldberg proposed a frequentist d…
stat.ME2024
Optimal Bayesian predictive probability for delayed response in single-arm clinical trials with binary efficacy outcome
Takuya Yoshimoto, Satoru Shinoda, Kouji Yamamoto +1
In oncology, phase II or multiple expansion cohort trials are crucial for clinical development plans. This is because they aid in identifying potent agents with sufficient activity…